Item 7.01 Regulation FD Disclosure. On February 9, 2023, Tonix Pharmaceuticals Holding Corp. (the “Company”) announced preclinical data that demonstrates that a single dose vaccination with the Company’s TNX-801 product candidate was effective at protecting non-human primates from infection with monkeypox virus in a publication entitled, “Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge,” in the journal Viruses (the “Presentation”). A copy of the press release which discusses this matter is furnished hereto as Exhibit 99.01, and incorporated herein by reference. The Company updated its investor presentation, which is u(…)
The Latest Press Releases